首页> 外文期刊>Crystal growth & design >Impact of Monomeric versus Micellar Surfactant and Surfactant-Polymer Interactions on Nucleation-Induction Times of Atazanavir from Supersaturated Solutions
【24h】

Impact of Monomeric versus Micellar Surfactant and Surfactant-Polymer Interactions on Nucleation-Induction Times of Atazanavir from Supersaturated Solutions

机译:单体对胶束表面活性剂和表面活性剂 - 聚合物相互作用对超饱和溶液的亚扎沙达韦核诱导时间的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Supersaturating formulations such as amorphous solid dispersions (ASDs) can lead to solution concentrations much higher than the crystalline solubility achieving enhanced oral bioavailability of poorly aqueous soluble compounds. However, they can potentially crystallize with a loss of their solubility advantage. Various polymers have been extensively used to delay crystallization. Increasingly, surfactants are being incorporated into ASDs to improve processing and dissolution performance. While the effect of polymers has been widely studied, the impact of surfactants on crystallization has not yet been explored to the same extent. In this work, the effect of a commonly used surfactant, sodium dodecyl sulfate (SDS) on the nucleation induction time (NIT) of a model compound, atazanavir (ATZ) was studied. NITs of supersaturated solutions with the same supersaturation ratio (SR) were measured in the presence of various SDS concentrations, ranging from well below the critical micelle concentration (CMC) to well above CMC, in order to evaluate the impacts of monomeric SDS molecules versus SDS micelles. SDS was found to promote crystallization at a certain minimum SDS concentration (critical hemimicelle concentration, CHMC). Further, no additional decrease in NIT was observed once the CMC of SDS was exceeded. To elucidate the mechanism of crystallization induction, fluorescence studies were carried out with crystal slurries. Fluorescence data strongly suggest that SDS hemimicelles present on the nucleus/crystal surface are responsible for the observed shortened induction times in ATZ nucleation. These adsorbed SDS hemimicelles can reduce the crystal-water interfacial energy, promoting nucleation. The combined effect of polymer and surfactant, using concentrations relevant to those produced upon ASD dissolution, was also studied. In the absence of SDS, the polymers inhibited detectable nucleation for >1000 min. In the presence of SDS, cellulosic polymers such as hydroxypropyl methyl cellulose 606 (HPMC-606) and hydroxypropyl methyl cellulose acetate succinate MF (HPMCAS-MF) maintained a similar level of inhibitory effect, whereas polyvinylpyrrolidone/vinyl acetate (PVPVA) lost some of its inhibitory effect.
机译:超饱和配方如无定形固体分散体(ASDS)可以导致溶液浓度远高于达到含水可溶性差的口服生物利用度的结晶溶解度。然而,它们可能会因其溶解性优势而丧失。各种聚合物已被广泛地用于延迟结晶。越来越多地,表面活性剂被掺入ASDs中以改善加工和溶解性能。虽然聚合物的效果已被广泛研究,但表面活性剂对结晶的影响尚未探讨相同的程度。在这项工作中,研究了常用的表面活性剂,十二烷基硫酸钠(SDS)对模型化合物,Atazanavir(ATZ)的成核诱导时间(NIT)的影响。在各种SDS浓度存在下测量具有相同叠加率比(SR)的超饱和溶液的溶液,从低于临界胶束浓度(CMC)到高于CMC,以评估单体SDS分子与SDS的影响胶束。发现SDS以某个最小SDS浓度(临界半纤维浓度,CHMC)促进结晶。此外,一旦超过SDS的CMC,未观察到镍氢镍的额外降低。为了阐明结晶诱导的机制,用晶体浆料进行荧光研究。荧光数据强烈表明,核/晶体表面上存在的SDS血管有负责ATZ成核中观察到的缩短诱导时间。这些吸附的SDS血管可降低晶体 - 水界面能量,促进核心。还研究了聚合物和表面活性剂的综合作用,使用与ASD溶解产生的浓度相关的浓度。在不存在SDS的情况下,聚合物抑制> 1000分钟的可检测成核。在SDS存在下,纤维素聚合物如羟丙基甲基纤维素606(HPMC-606)和羟丙基甲基纤维素乙酸盐MF(HPMCA-MF)保持着类似的抑制作用水平,而聚乙烯基吡咯烷酮/乙酸乙烯酯(PVPVA)失去了一些它的抑制作用。

著录项

  • 来源
    《Crystal growth & design》 |2020年第1期|共11页
  • 作者单位

    Purdue Univ Coll Pharm Dept Ind &

    Phys Pharm 575 Stadium Mall Dr W Lafayette IN 47907 USA;

    AbbVie Inc Sci &

    Technol S&

    T Operat N Chicago IL 60064 USA;

    AbbVie Inc Sci &

    Technol S&

    T Operat N Chicago IL 60064 USA;

    AbbVie Inc Drug Product Dev Res &

    Dev 1 N Waukegan Rd N Chicago IL 60064 USA;

    Purdue Univ Coll Pharm Dept Ind &

    Phys Pharm 575 Stadium Mall Dr W Lafayette IN 47907 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 晶体学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号